![]() |
市场调查报告书
商品编码
1856945
全球血液银行和储存设备市场:预测至2032年-按产品、技术、应用、最终用户和地区分類的分析Blood Banking & Storage Equipment Market Forecasts to 2032 - Global Analysis By Product (Blood Storage Refrigerators, Blood Transport Systems, Blood Plasma Freezers and Other Products), Technology, Application, End User and By Geography |
||||||
据 Stratistics MRC 称,全球血库和储存设备市场预计到 2025 年将达到 170 亿美元,到 2032 年将达到 234 亿美元,预测期内复合年增长率为 4.6%。
血库和血液储存设备是指用于采集、处理、保存和储存血液及其成分的专用医疗设备和系统。这包括血液冰箱、血浆冷冻库、血小板培养箱、离心机、血库分析仪等。这些设备旨在维持最佳温度和无菌状态,确保用于输血和医疗程序的血液製品的安全性、有效性和可追溯性。它们在医院、诊断实验室和血库中发挥着至关重要的作用,有助于高效的库存管理、合规性和紧急准备。先进的技术还实现了自动化、即时监控和更精准的供受者匹配,从而带来更好的医疗效果。
输血需求增加
输血需求的不断成长是血液银行和储存设备市场的主要驱动力。创伤、手术、癌症和贫血等慢性疾病病例的增加以及人口老化,都促使人们对安全高效的血液储存方式提出了更高的要求。医院和医疗机构正在扩大血液管理能力,这进一步推动了对先进储存设备的需求。此外,人们对自愿捐血的认识不断提高,以及医疗系统对紧急准备的日益重视,也进一步促进了这一趋势。
先进设备高成本
先进的血库和血库设备成本高昂,是限制市场成长的主要因素。诸如血浆冷冻机、自动化分析仪和温控储存设备等先进设备需要大量的资金投入。这些成本对于规模较小的医疗机构和血库而言可能难以承受,尤其是在发展中地区。此外,持续的维护、校准以及遵守监管标准也会增加营运成本。这些经济负担会限制资源匮乏地区对先进设备的采用,并延缓现代化进程。
技术进步
技术进步为市场带来了巨大的机会。自动化血液处理系统、RFID库存追踪和智慧温度监控等创新技术提高了效率、安全性和可追溯性。这些技术减少了人为错误,改善了储存条件,并有助于符合监管要求。与数位健康平台和即时数据分析的整合也有助于更好地进行决策和供受者配对。随着医疗保健系统的现代化,对智慧、互联和节能储存解决方案的需求预计将推动市场显着成长。
严格的监管要求
严格的监管要求对市场构成重大威胁。遵守血液安全、储存和可追溯性的国际标准需要严格的测试、记录和认证。这些法规可能会延迟产品核准,并增加製造商的研发成本。此外,安全通讯协定和品管措施的频繁更新也要求持续调整。对于医疗服务提供者而言,满足这些标准需要培训、审核和基础设施升级,这可能会耗费资源并阻碍新技术的应用。
新冠疫情对血库和血液储存设备市场产生了多方面的影响。虽然择期手术减少,但对康復者血浆和紧急血液供应的需求却激增。这场危机凸显了健全的血液储存基础设施的重要性,并加速了自动化和非接触式技术的应用。供应链中断和捐血者短缺带来了挑战,但也推动了行动采血车和远端监控系统的创新。预计疫情后市场将受益于对医疗保健韧性和紧急准备的重新投资。
预计在预测期内,诊断中心板块将成为最大的细分市场。
由于诊断中心数量不断增加,且在血液检测、交叉配血和疾病筛检方面发挥至关重要的作用,预计在预测期内,诊断中心细分市场将占据最大的市场份额。这些中心需要可靠的储存解决方案来维持血液样本和成分的完整性。随着对精准诊断和预防性医疗保健需求的不断增长,诊断中心正在投资先进设备,以确保合规性、缩短週转时间并支援日益增长的血液相关检测服务量。
预计在预测期内,血浆冷冻机细分市场将实现最高的复合年增长率。
由于血浆在免疫力缺乏、出血性疾病和新冠肺炎相关治疗等领域的应用日益广泛,预计血浆冷冻设备领域在预测期内将达到最高成长率。血浆需要超低温储存才能保持其疗效,这推动了对专用冷冻库的需求。能源效率、温度控制和警报系统等技术进步进一步提升了产品的吸引力。随着血浆疗法在全球范围内的推广,对可靠且扩充性的储存解决方案的需求也在持续增长。
预计亚太地区将在预测期内占据最大的市场份额。人口快速增长、医疗保健投资不断增加以及捐血意识的提高是该地区的主要驱动因素。中国、印度和日本等国家正在扩大医疗保健基础设施并引进先进的医疗技术。政府为提高血液安全性和供应量而采取的倡议,以及慢性病负担的日益加重,进一步推动了全部区域对现代化血液储存和处理设备的需求。
预计北美在预测期内将实现最高的复合年增长率。这主要归功于该地区先进的医疗基础设施、健全的法规结构以及对最尖端科技的广泛应用。血液成分需求的成长、慢性病盛行率的上升以及完善的血库和诊断中心网络也推动了这一趋势。此外,输血医学领域的持续研究以及数位医疗解决方案的整合,使北美在血库创新和扩张方面处于领先地位。
According to Stratistics MRC, the Global Blood Banking & Storage Equipment Market is accounted for $17.0 billion in 2025 and is expected to reach $23.4 billion by 2032 growing at a CAGR of 4.6% during the forecast period. Blood banking and storage equipment refers to specialized medical devices and systems used for the collection, processing, preservation, and storage of blood and its components. These include blood refrigerators, plasma freezers, platelet incubators, centrifuges, and blood bank analyzers. Designed to maintain optimal temperature and sterility, this equipment ensures the safety, viability, and traceability of blood products for transfusions and medical procedures. It plays a critical role in hospitals, diagnostic labs, and blood banks by supporting efficient inventory management, regulatory compliance, and emergency preparedness. Advanced technologies also enable automation, real-time monitoring, and improved donor-to-recipient matching for better healthcare outcomes.
Increasing demand for blood transfusions
The growing demand for blood transfusions is a key driver of the Blood Banking & Storage Equipment Market. Rising incidences of trauma, surgeries, chronic diseases like cancer and anemia, and aging populations are increasing the need for safe and efficient blood storage. Hospitals and healthcare facilities are expanding their blood management capabilities, which boost the demand for advanced storage equipment. This trend is further supported by growing awareness of voluntary blood donation and the need for emergency preparedness in healthcare systems.
High cost of advanced equipment
The high cost of advanced blood banking and storage equipment poses a significant restraint to market growth. Sophisticated devices such as plasma freezers, automated analyzers, and temperature-controlled storage units require substantial capital investment. These costs can be prohibitive for smaller healthcare facilities and blood banks, particularly in developing regions. Additionally, ongoing maintenance, calibration, and compliance with regulatory standards add to operational expenses. This financial burden may limit adoption and slow modernization efforts in resource-constrained environments.
Technological advancements
Technological advancements present a major opportunity for the market. Innovations such as automated blood processing systems, RFID-enabled inventory tracking, and smart temperature monitoring enhance efficiency, safety, and traceability. These technologies reduce human error, improve storage conditions, and support regulatory compliance. Integration with digital health platforms and real-time data analytics also enables better decision-making and donor-recipient matching. As healthcare systems modernize, the demand for intelligent, connected, and energy-efficient storage solutions is expected to drive significant market growth.
Stringent regulatory requirements
Stringent regulatory requirements represent a key threat to the market. Compliance with international standards for blood safety, storage, and traceability demands rigorous testing, documentation, and certification. These regulations can delay product approvals and increase development costs for manufacturers. Additionally, frequent updates to safety protocols and quality control measures require continuous adaptation. For healthcare providers, meeting these standards involves training, audits, and infrastructure upgrades, which can strain resources and hinder the adoption of new technologies.
The COVID-19 pandemic had a mixed impact on the Blood Banking & Storage Equipment Market. While elective procedures declined, the need for convalescent plasma and emergency blood supplies surged. The crisis highlighted the importance of robust blood storage infrastructure and accelerated the adoption of automated and contactless technologies. Supply chain disruptions and donor shortages posed challenges, but also spurred innovation in mobile collection units and remote monitoring systems. Post-pandemic, the market is expected to benefit from renewed investments in healthcare resilience and preparedness.
The diagnostic centers segment is expected to be the largest during the forecast period
The diagnostic centers segment is expected to account for the largest market share during the forecast period, due to increasing number of diagnostic laboratories and their critical role in blood testing, cross-matching, and disease screening. These centers require reliable storage solutions to maintain the integrity of blood samples and components. With rising demand for accurate diagnostics and preventive healthcare, diagnostic centers are investing in advanced equipment to ensure compliance, improve turnaround times, and support growing volumes of blood-related testing services.
The blood plasma freezers segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the blood plasma freezers segment is predicted to witness the highest growth rate, due to increasing use of plasma in therapeutic applications, including treatment for immune deficiencies, bleeding disorders, and COVID-19-related therapies. Plasma requires ultra-low temperature storage to preserve its efficacy, driving demand for specialized freezers. Technological improvements in energy efficiency, temperature control, and alarm systems are further enhancing product appeal. As plasma-based treatments expand globally, the need for reliable and scalable storage solutions continues to rise.
During the forecast period, the Asia Pacific region is expected to hold the largest market share, as rapid population growth, increasing healthcare investments, and rising awareness of blood donation are key drivers in the region. Countries like China, India, and Japan are expanding their healthcare infrastructure and adopting advanced medical technologies. Government initiatives to improve blood safety and availability, along with the growing burden of chronic diseases, are further boosting demand for modern blood storage and processing equipment across the region.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to region's advanced healthcare infrastructure, strong regulatory framework, and high adoption of cutting-edge technologies. Increasing demand for blood components, rising prevalence of chronic illnesses, and a well-established network of blood banks and diagnostic centers contribute to this trend. Additionally, ongoing research in transfusion medicine and the integration of digital health solutions position North America as a leader in blood storage innovation and expansion.
Key players in the market
Some of the key players in Blood Banking & Storage Equipment Market include Thermo Fisher Scientific, Angelantoni Life Science, Haier Biomedical, Labcold Ltd, Terumo Corporation, Panasonic Healthcare, Fresenius Kabi, Sarstedt AG & Co. KG, Bio-Rad Laboratories, Boekel Scientific, Becton, Dickinson and Company (BD), Lmb Technologie GmbH, Azenta Life Sciences, Macopharma, and Helmer Scientific.
In July 2025, Thermo Fisher will acquire Sanofi's sterile manufacturing facility in Ridgefield, New Jersey and continue producing Sanofi's therapies there. They also plan to expand the site's capacity to serve broader pharmaceutical and biotech demand. More than 200 existing staff will join Thermo Fisher as the transaction closes in the second half of 2025.
In January 2025, Pioneer Group and Thermo Fisher Scientific unite to bolster UK and Irish biotech startups. This collaboration offers entrepreneurs access to training, technical support, bespoke equipment, and consumables. Graduates of Pioneer's equity-free Accelerator Programme gain exclusive access to Thermo Fisher's reward system, aiding in laboratory setup.